Norepinephrine reuptake inhibitor

From Free net encyclopedia

Norepinephrine reuptake inhibitors (NRIs) are compounds that elevate the extracellular level of the neurotransmitter norepinephrine in the CNS by inhibiting its reuptake into the synapse via the norepinephrine transporter. Virtually, they do not act at other monoamine transporters.

List of NRIs

Strattera® is available in the United States and is indicated by the FDA for the treatment of ADD and ADHD, off-label uses include the treatment of depression, and anxiety.

Reboxetine, unavailable in the United States and Canada, has been found to be effective at combating depression.


Antidepressants (ATC N06A) edit
Monoamine oxidase inhibitors: {Harmaline} {Nialamide} {Selegiline} {Isocarboxazid} {Iproniazid} {Iproclozide} {Moclobemide} {Phenelzine} {Toloxatone} {Tranylcypromine}

Dopamine reuptake inhibitors: {Bupropion} {Amineptine}

Norepinephrine reuptake inhibitors: {Atomoxetine} {Reboxetine} {Viloxazine} {Maprotiline}

Serotonin-norepinephrine reuptake inhibitors: {Desipramine} {Duloxetine} {Milnacipran} {Nefazodone} {Venlafaxine}

Selective serotonin reuptake inhibitors: {Alaproclate} {Etoperidone} {Citalopram} {Escitalopram} {Fluoxetine} {Fluvoxamine} {Paroxetine} {Sertraline} {Zimelidine}

Selective serotonin reuptake enhancers: {Tianeptine}

Tricyclic antidepressants: {Amitriptyline} {Clomipramine} {Desipramine} {Dothiepin} {Doxepin} {Imipramine} {Lofepramine} {Nortriptyline} {Protriptyline} {Trimipramine} {Iprindole} {Opipramol}

Tetracyclic antidepressants: {Maprotiline} {Mianserin} {Mirtazapine} {Amoxapine}

Template:Treatment-stub

he:SNRI